Effectiveness of Alveolar Bone Preservation in Alveoli With Infectious Process

NCT ID: NCT06661863

Last Updated: 2024-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-15

Study Completion Date

2029-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alveolar ridge preservation (ARP) is a surgical technique that aims to minimize the degree of dimensional changes following extraction. In the healing period after extraction, the alveolar bone (AB) undergoes morphological changes during the remodeling process. The changes become evident immediately after tooth extraction, with greater resorption changes observed during the first two months, and these dimensional changes can be observed 1 year after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alveolar Bone Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study includes 28 patients who have a tooth extraction indicated in reference to g. avila-ortiz et al. 2020. They will be divided into 2 randomized groups, 14 sockets with an infectious process will be preserved with autologous bone and the remaining 14 with 58s bioactive glass
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The participants will not know wich biomaterial will be grafted

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

autologous bone

An autologous bone graft is defined as a living tissue capable of promoting bone healing by transferring that tissue from a donor area to a recipient area. It has been defined as the "gold standard" for having the capacity for osteogenesis, osteoinduction, osteoconduction and providing good structural support, showing high biocompatibility and low immunogenicity, however, autologous bone is limited and has greater morbidity due to the collection of autologous bone from the donor site, increased surgical time, greater infection, inflammation, pain and bleeding.

Group Type ACTIVE_COMPARATOR

alveolar ridge preservation with autologous bone

Intervention Type PROCEDURE

Autologous bone graft in alveolar ridge preservation.

Bioactive glass

Bioactive glasses (VB) are a group of synthetic ceramics based on silicates coupled with other minerals. Desirable properties of VB include good biocompatibility, osteoconductivity, antimicrobial activity and a porous structure that promotes vascularization

Group Type EXPERIMENTAL

alveolar ridge preservation with bioactive glass

Intervention Type PROCEDURE

Bioactive glass grafted into alveolar preservation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

alveolar ridge preservation with bioactive glass

Bioactive glass grafted into alveolar preservation.

Intervention Type PROCEDURE

alveolar ridge preservation with autologous bone

Autologous bone graft in alveolar ridge preservation.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years of age
* Patients with indicated tooth extractions
* Patients who have accepted the conditions of the study

Exclusion Criteria

* Pregnant patients, breastfeeding or using oral contraceptives
* Smoking patients
* Patients with uncontrolled systemic diseases
* History of autoimmune disease
* Previous traumatic extraction
* Patients taking bisphosphonates or anticoagulants
* Patients who are or have undergone chemotherapy and radiotherapy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Especialidades Espiritu Santo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Antonio Lanata Flores

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidadees

Samborondón, Guayas, Ecuador

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ecuador

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Antonio G Lanata, 5 level

Role: primary

+593983820084

Daniel L Campoverde, 3 level

Role: backup

+593984364517

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-ODONT-002C

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.